Statera BioPharma, Inc.

Industry

  • Pharmaceuticals
    • Vaccines
  • Biotechnology

Other Names/Subsidiaries

  • Cleveland BioLabs
  • Cytocom
  • leveland BioLabs
  • mQuest Life Sciences
See more in Biomedtracker

Latest on Statera BioPharma, Inc.

Scrip

Deal Watch: FTC Keeps Current Merger Guidelines In Place, For Now

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Trump Appointee Ferguson Keeps Biden-E

Scrip

Deal Watch: Vertex Calls On CRISPR Yet Again, Now To Collaborate On Type 1 Diabetes

 
• By Joseph Haas and Mandy Jackson

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. New Vertex/CRISPR Pact Centers On Gene-

Scrip

Deal Watch: Innoviva To Buy The Rest Of Entasis For Enterprise Value Of $113m

 
• By Joseph Haas and Ayisha Sharma

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Innoviva Acquisition Of Entasis Leaves

Scrip

Deal Watch: Dragonfly Adds Gilead To Its List Of Big-Name Partners

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets 5T4-Targeted NK Cell Therap